Research Protocols / Healing
TB-500 research protocols: actin dynamics, not just repair
TB-500 is usually filed under tissue repair, which undersells it. The underlying mechanism is control of actin polymerisation, a process that touches migration, angiogenesis, and cytoskeletal remodelling across many cell types.
TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a 43-residue protein present in most mammalian cell types and one of the most abundant intracellular proteins in many of them. The distinction between TB-500 and full-length Thymosin Beta-4 matters when reading literature: most published mechanistic work uses the full protein, while most commercially supplied research material is the fragment.
The actin mechanism
Thymosin Beta-4's defining biochemical property is G-actin sequestration. Actin exists in two states: monomeric globular actin (G-actin) and polymerised filamentous actin (F-actin). The ratio between them governs whether a cell can remodel its cytoskeleton, which in turn governs whether it can migrate, change shape, or extend processes.
Thymosin Beta-4 binds G-actin monomers and holds them in a reserve pool, buffering the free monomer concentration. That buffering is not simply inhibitory. By maintaining a controlled reservoir, it allows rapid, directed polymerisation when a signal arrives, rather than the uncontrolled polymerisation that would occur with a large free monomer pool.
| Process | Actin dependence | Research relevance |
|---|---|---|
| Cell migration | Lamellipodial actin polymerisation at the leading edge | Wound bed repopulation, fibroblast recruitment |
| Angiogenesis | Endothelial cell migration and tube formation | Perfusion of repairing tissue |
| Cardiac models | Cardiomyocyte survival and epicardial cell activation | A substantial published literature independent of wound healing |
| Corneal and dermal models | Epithelial migration across a defect | Among the earliest studied applications |
Filing TB-500 under healing is a category error that hides half the literature. The mechanism is cytoskeletal, and the repair phenotype is downstream of it.
Reconstitution for 5 mg and 10 mg vials
We supply TB-500 in a 5 mg vial and a 10 mg vial, both lyophilized.
| Vial | Water added | Concentration | Per 0.1 mL |
|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 500 mcg |
| 5 mg | 2.5 mL | 2 mg/mL | 200 mcg |
| 10 mg | 2 mL | 5 mg/mL | 500 mcg |
| 10 mg | 5 mL | 2 mg/mL | 200 mcg |
Stability: the one real caution
TB-500 is less freeze-thaw tolerant than the short linear peptides it is usually grouped with. Thymosin Beta-4 fragments carry more secondary structure than a 15-residue peptide like BPC-157, and structured peptides lose activity faster across freeze-thaw cycles because ice crystal formation disrupts folding. Published stability figures for structured peptide fragments cluster around 3 to 5 percent activity loss per cycle against roughly 1 to 3 percent for short linear peptides.
Practical consequence: aliquot. If you expect more than three access events from one reconstituted vial, split it into single-use tubes at the time of reconstitution. Our freeze-thaw guide covers the aliquoting protocol in full.
The BPC-157 pairing
TB-500 and BPC-157 are frequently studied together because their mechanisms are complementary rather than overlapping: actin-dependent cell migration on one side, angiogenic signalling and fibroblast behaviour on the other. We cover the comparison in BPC-157 versus TB-500 and the combination protocol in the blend research guide. The lot-matched pre-blended vial is available if you want both from a single certificate.
Sourcing and verification
Purity determines whether a result is reproducible. Every Lumera Labs lot ships with a lot-specific certificate of analysis reporting HPLC-UV purity, and those certificates are published at Lab Results before you order rather than emailed afterward. Orders ship from within Canada in 24 to 48 hours, free over $200 CAD, which removes customs exposure and keeps transit short for temperature-sensitive material.
FAQ
Is TB-500 the same as Thymosin Beta-4?
No. Thymosin Beta-4 is the full 43-residue protein; TB-500 is a synthetic peptide corresponding to its active region. Most published mechanistic work uses the full protein, so read literature with that distinction in mind.
What does G-actin sequestration actually do?
It buffers the free actin monomer pool. Rather than simply inhibiting polymerisation, that reserve allows rapid directed polymerisation when a signal arrives, which is what enables controlled cell migration and cytoskeletal remodelling.
How do I reconstitute a 5 mg or 10 mg TB-500 vial?
For 5 mg, 1 mL gives 5 mg/mL and 2.5 mL gives 2 mg/mL. For 10 mg, 2 mL gives 5 mg/mL and 5 mL gives 2 mg/mL. Add solvent down the vial wall and swirl rather than shake.
Is TB-500 freeze-thaw sensitive?
More so than short linear peptides. Structured peptide fragments lose roughly 3 to 5 percent activity per cycle against 1 to 3 percent for short linear peptides, so aliquot into single-use tubes if you expect more than three access events.
Why is TB-500 studied in cardiac models?
Because the mechanism is cytoskeletal rather than wound-specific. Published cardiac work examines cardiomyocyte survival and epicardial cell activation, both of which depend on actin dynamics.
Continue reading